May 2 - 6, 2026 | Denver, CO, USA | Booth #9065

StageBio is excited to attend the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting in Denver, Colorado this May. Our team will be on-site and ready to connect with you to discuss how we can support your ophthalmic drug and medical device development programs. Whether you're advancing early discovery, GLP studies, or late-stage development, we're here to explore how our scientific expertise and specialized ocular pathology services can help drive your programs forward.

Visit us at Booth #9065 to connect with our team and learn how StageBio's collaborative approach to ocular histopathology delivers the precision, quality, and regulatory confidence sponsors need to bring safe and effective therapies to market.

Meet Our Team

	Jolanda Verhoef, DVM, MSc, DACVP  Veterinary Pathologist Jolanda Verhoef is a board-certified veterinary pathologist (DACVP) with advanced training in comparative and translational pathology. Holding a DVM and MSc, she brings deep expertise in ocular pathology and histopathologic evaluation across multiple species and therapeutic modalities. Jolanda's scientific rigor and attention to detail make her a trusted partner for sponsors navigating the complex pathology demands of ophthalmic drug and device development.
	Ailsa Delgado  Senior Account Manager Ailsa Delgado is a Senior Account Manager at StageBio with more than 18 years of experience fostering strategic partnerships across pharmaceutical, biotech, government, and academic organizations. She takes a deeply customer-centric approach to supporting non-clinical and clinical programs, working closely with clients to align goals, study needs, and expertise, driving long-term collaboration and successful program outcomes.
	Anthony Rohr  Business Development Executive Anthony Rohr is a Business Development Executive at StageBio with more than two decades of experience in contract research and development. With a background spanning CRO operations, regulatory frameworks, and commercial strategy, he helps clients navigate complex preclinical workflows with confidence. Known for a consultative, efficiency-driven approach, Anthony supports scalable growth and strong client partnerships.

StageBio's Expertise in Ocular Pathology

StageBio provides comprehensive pathology services to support ophthalmic drug and medical device development. Our capabilities include:

• Ocular Pathology: Specialized expertise in the histopathologic evaluation of ocular tissues across major preclinical species, supporting both GLP and non-GLP studies from discovery through regulatory submission, including study design, reporting, and peer review.

• Pathology Expertise: 20+ pathologists working across sites, providing specialized expertise in organ systems, including ocular, and therapeutic modalities such as biologics, cell and gene therapy, and medical devices. Deliverables include reports, peer reviews, consulting, and tailored support for complex client needs.

• Specialized Histology Expertise: High-quality, reproducible histology supported by advanced capabilities including IHC/IF assay development, custom biomarker validation, plastic embedding for ocular and hard tissues, and precision histotechnology workflows designed for the unique demands of ophthalmic studies.

Whether you're developing a small molecule, biologic, gene therapy, or ocular medical device, StageBio's team brings the proven expertise and regulatory insight needed to advance your program with confidence.

Connect With Us

Stop by Booth #9065 to discuss your pathology needs, explore partnership opportunities, or simply connect with our team. We look forward to seeing you in Denver!

For more information about StageBio's preclinical pathology services, contact us or visit our check out our Ocular Histopathology Services.

Register for ARVO 2026!